InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.90
(
0.02%
)
US TECH 100
19,394.40
(
-0.07%
)
Dow Jones
38,930.47
(
0.25%
)
Brent Oil
84.74
(
0.05%
)
Bitcoin
64,724.64
(
-0.40%
)
Post# of 41063
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BERKSHIRE AGENT

Send PM Follow Ignore
Followers 5427
Posts 149175
Boards Moderated 2
Alias Born 02/17/2010

BERKSHIRE AGENT

Member Level

Re: None

Saturday, 01/21/2012 4:18:36 PM

Saturday, January 21, 2012 4:18:36 PM

Post# of 41063
SNDY (Solos Endoscopy).0010 cents and the most undervalued Biotech health stock perhaps ever imo. On Sept. 17th 2009 news regarding contracts with various Cancer Institutes skyrocketed this stock from .0030 cents to .024 cents. Now with a ton of sales on their latest mammoview breast cancer devices + a number of various things in the pipelines as well as CE mark pending the stock could easily see beyond .02+ cents again shortly. The time to buy SNDY is NOW and reap the profits thereafter imo. Support the women of the world today and help beat the fight against breast cancer. Invest for a good cause and let your investment reward you numerous times in the very near future imo.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up